HDT Bio Corp.
PrivateLast Round
Grant
Sep 17, 2024
Total Funding Raised
$73.25M
Company Overview
HDT Bio Corp. is a biotechnology company developing drugs and vaccines for the immunotherapy of cancers and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HDT Bio Corp. Comparables
Compare HDT Bio Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entos Pharmaceuticals | 85% | |
| Genevant Sciences | 83% | |
| Acuitas Therapeutics | 83% |
HDT Bio Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Jan 23, 2024 | ||||
| Grant | Oct 4, 2023 | ||||
| Grant | Nov 30, 2022 | ||||
| Grant | Aug 8, 2022 | ||||
Grant | Jul 20, 2022 |
HDT Bio Corp. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2025
Developing a vaccine platform in collaboration with RML, currently in animal model evaluations.
- Jan 23, 2024
$749K grant received from BARDA and PHEMCE.
Recent news
Latest coverage and updates
- receives_financingSep 15, 2026
HDT Bio Corp. received financing of $5.2M in Phase 1 funding on Sep 15th '26.
- receives_awardSep 15, 2026
HDT Bio Corp. received award ARPA-H GIVE on Sep 15th '26.
- is_developingSep 8, 2026
HDT Bio Corp. is developing integrated platform on Sep 11th '26.
- partners_withJul 12, 2026
HDT Bio partnered with McGill University on Jul 12th '26.
- partners_withJul 12, 2026
HDT Bio partnered with The Neuro on Jul 12th '26.
HDT Bio Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HDT Bio Corp.'s valuation, stock price, and market status.
Is HDT Bio Corp. a public or private company?
HDT Bio Corp. is a private company.
What is the current stock price of HDT Bio Corp.?
HDT Bio Corp. is a private company with no public stock price. No recent secondary market data is available.
How much is HDT Bio Corp. worth (valuation)?
Valuation information for HDT Bio Corp. is not publicly available.
Can I buy HDT Bio Corp. stock?
HDT Bio Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HDT Bio Corp.'s last funding round?
HDT Bio Corp.'s most recent funding round was Grant on September 17, 2024.
Who are the main investors in HDT Bio Corp.?
Key investors in HDT Bio Corp. include Zoic Capital.
Will HDT Bio Corp. IPO soon?
No public IPO plans have been announced for HDT Bio Corp..
How can I track HDT Bio Corp. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HDT Bio Corp.'s secondary market activity and sign up for updates.